Nom du produit:1-bromo-4-fluoro-2-methoxybenzene

IUPAC Name:1-bromo-4-fluoro-2-methoxybenzene

CAS:450-88-4
Formule moléculaire:C7H6BrFO
Pureté:95%+
Numéro de catalogue:CM100426
Poids moléculaire:205.03

Unité d'emballage Stock disponible Prix($) Quantité
CM100426-100g in stock ǧǕǧ

Pour une utilisation en R&D uniquement..

Formulaire de demande

   refresh    

Détails du produit

N° CAS:450-88-4
Formule moléculaire:C7H6BrFO
Point de fusion:-
Code SMILES:COC1=CC(F)=CC=C1Br
Densité:1.5983 g/mL
Numéro de catalogue:CM100426
Poids moléculaire:205.03
Point d'ébullition:187.9°C at 760 mmHg
N° Mdl:MFCD04973752
Stockage:Store at 2-8°C.

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Halides
In chemistry, a halide is a binary chemical compound, of which one part is a halogen atom and the other part is an element or radical that is less electronegative (or more electropositive) than the halogen, to make a fluoride, chloride, bromide, iodide, astatide, or theoretically tennesside compound.
Enitociclib
On January 7, 2024, Vincerx announced promising clinical results from a Phase 1 NIH-sponsored study of enitociclib in combination with venetoclax and prednisone for the treatment of relapsed/refractory lymphoma. Enitociclib is a highly selective CDK9 inhibitor that prevents activation of RNA polymerase II, resulting in reduction of known oncogenes MYC and MCL1.

Related Products